The team at Meridius Bio isn't leaving longevity to chance. They are taking luck out of the equation for millions affected by heart disease, diabetes, and a multitude of other illnesses and accidents that cause wounds and tissue damage. With their revolutionary (and that isn't hyperbole) development of AIMER (Active Immuno-Modulated Enhanced Regeneration) Nanotherapeutic, they plan to restore health and increase longevity for millions.
Healthcare Health/Fitness
Redefining Vision Care: EyeQue's Product Suite Leads the Market Change and Improves Accessibility
EyeQue, inspired by the late Zenni founder Tibor Laczay and led by CEO John A. Serri along with his strong and innovative leadership team, including COO Nicole Skibinski, CTO Noam Sapiens, CFO Kathy Chueh, among others, are dedicated to changing the statistics and democratizing vision care worldwide.
Four Deaths May Be Linked to Dietary Supplements Made by Japan’s Kobayashi Pharmaceutical: Report
Four fatalities and over 100 hospitalizations may have been caused by nutritional supplements from Kobayashi Pharmaceutical.
Winrevair: Merck’s Drug for Rare, Deadly Lung Condition Gets FDA Approval
Merck has received approval from the Food and Drug Administration (FDA) for its new drug, Winrevair, designed to treat a rare and deadly lung condition.
South Korea’s Senior Doctors to Resign in Protest Over Medical School Expansion
As the physicians' strike in South Korea grows, medical professors and doctors warn they will cut their hours or quit.
Latest News
Nvidia has partnered with Johnson & Johnson to develop new AI applications to help doctors perform surgery.
UnitedHealth Group announced progress in managing the repercussions of a major cyberattack on the US health system and Change Healthcare.
The US Food and Drug Administration (FDA) has approved Madrigal Pharmaceuticals' Rezdiffra, the first drug to treat serious liver disease.
Microsoft collaborates with Stanford Medicine to introduce Nuance Dragon Ambient eXperience Copilot (DAX Copilot), an AI tool that simplifies paperwork for doctors and improves patient care, addressing burnout concerns in healthcare.
Shionogi preps U.S. launch of Xocova for 2025 amid Japan's funding cuts for COVID meds. Pfizer's Paxlovid shows declining real-world efficacy.
In the dynamic landscape of mental health, holistic therapies that nurture both personal and communal well-being are gaining prominence. Matt Zemon is focused on the thoughtful application of psychedelics within group environments to foster deep healing and expanded awareness. His approach is characterized by the use of these substances to spark profound self-discovery and collective insight.
Pfizer is shifting its focus from COVID-related products to cancer drugs. Pfizer is shifting its focus on cancer drugs as the pharmaceutical giant tries to recover from a challenging period due to the decline of its COVID-19 business.
Cigna broadens coverage for weight loss drugs, capping spending increases at 15%. To address rising costs, it expands programs for diabetes and obesity management.
The tools, Einstein Copilot: Health Actions, will help schedule appointments, while the Assessment Generation will digitize health assessments to ease administrative burdens and improve patient care outcomes.
